Figure 5 from Coordinated Targeting of S6K1/2 and AXL Disrupts Pyrimidine Biosynthesis in PTEN-Deficient Glioblastoma
Catherine A. Behrmann(University of Cincinnati Medical Center), David R. Plas(Howard Hughes Medical Institute), Ady Kendler(University of Cincinnati Medical Center), Subrahmanya Vallabhapurapu(University of Cincinnati Medical Center), Jann N. Sarkaria(Mayo Clinic in Arizona), Xiaoyang Qi(University of Cincinnati Medical Center), P.N. Sarma(University of Cincinnati Medical Center), Pier Paolo Scaglioni(University of Cincinnati), Nicholas A. Clark(Harvard University), Cristina Andreani(Università di Camerino), Biplab Dasgupta(Emory University), Mario Medvedovic(University of Cincinnati), Collin Wetzel(University of Cincinnati Medical Center), James Reigle(Cincinnati Children's Hospital Medical Center), Jarek Meller(Cincinnati Children's Hospital Medical Center), Kelli N. Ennis(University of Cincinnati Medical Center), Maria Czyzyk-Krzeska(University of Cincinnati Medical Center), Kate M. Von Handorf(University of Cincinnati Medical Center), Soma Sengupta(Tufts University)
Cited by 0
Related Papers
Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme
|Cell Metabolism|2007|899
The Mechanisms of PML-Nuclear Body Formation
|Molecular Cell|2006|517